A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction?

This publication has 49 references indexed in Scilit:

• Characterization of Patients With Heart Failure of Chagas Etiology in Colombia: An Analysis Based on the Colombian Registry of Heart Failure (RECOLFACA)
  Current Problems in Cardiology, 2023
• Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank
  European Journal of Heart Failure, 2022
• The Use of the CALL Risk Score for Predicting Mortality in Brazilian Heart Failure Patients
  ESC Heart Failure, 2020
• Cardiac magnetic resonance imaging in Chagas’ disease: a parallel with electrophysiologic studies
  The International Journal of Cardiovascular Imaging, 2020
• Immune-neuroendocrine and metabolic disorders in human and experimental T. cruzi infection: New clues for understanding Chagas disease pathology
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
• American Trypanosomiasis (Chagas Disease)
  Infectious Disease Clinics of North America, 2019
• Post Hoc Analyses of SHIFT and PARADIGM-HF Highlight the Importance of Chronic Chagas' Cardiomyopathy Comment on: “Safety Profile and Efficacy of Ivabradine in Heart Failure Due to Chagas Heart Disease: A Post Hoc Analysis of the SHIFT Trial” by Bocchi et al.
  ESC Heart Failure, 2018
• Safety Profile and Efficacy of Ivabradine in Heart Failure Due to Chagas Heart Disease: A Post Hoc Analysis of the SHIFT Trial
  ESC Heart Failure, 2017
• Prognostic impact of Chagas' disease in patients awaiting heart transplantation
  The Journal of Heart and Lung Transplantation, 2010
• Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease
  International Journal of Cardiology, 2005